Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AMGN

AMGEN Inc

Nov 07 • 02:09PM ET

319.31

+3.72 1.18 %

Healthcare • Drug Manufacturers - General • USA • NASD

Peers: BIIB GILD REGN VRTX BMY MRNA ILMN PFE NBIX ABBV

| Held by: VTI VOO QQQ SCHD IVV SPY DIA VTV XLV VIG

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	24.69	EPS (ttm)	12.94	Insider Own	0.21%	Shs Outstand	538.50M	Perf Week	7.00%
Market Cap	171.94B	Forward P/E	14.71	EPS next Y	21.71	Insider Trans	-0.24%	Shs Float	537.25M	Perf Month	8.08%
Enterprise Value	217.08B	PEG	5.73	EPS next Q	4.84	Inst Own	82.30%	Short Float	2.14%	Perf Quarter	12.00%
Income	7.00B	P/S	4.79	EPS this Y	7.08%	Inst Trans	-0.18%	Short Ratio	4.92	Perf Half Y	20.10%
Sales	35.89B	P/B	17.88	EPS next Y	2.20%	ROA	7.74%	Short Interest	11.48M	Perf YTD	22.51%
Book/sh	17.86	P/C	18.20	EPS next 5Y	4.31%	ROE	81.71%	52W High	335.88 -4.93%	Perf Year	0.01%
Cash/sh	17.54	P/FCF	14.90	EPS past 3/5Y	-9.75% -10.10%	ROIC	11.29%	52W Low	253.30 26.06%	Perf 3Y	18.70%
Dividend Est.	9.62 (3.01%)	EV/EBITDA	13.84	Sales past 3/5Y	8.54% 7.40%	Gross Margin	70.47%	Volatility	3.62% 2.31%	Perf 5Y	45.00%
Dividend TTM	9.39 (2.94%)	EV/Sales	6.05	EPS Y/Y TTM	65.22%	Oper. Margin	28.56%	ATR (14)	7.69	Perf 10Y	101.86%
Dividend Ex-Date	Nov 21, 2025	Quick Ratio	0.99	Sales Y/Y TTM	11.03%	Profit Margin	19.52%	RSI (14)	70.36	Recom	2.39
Dividend Gr. 3/5Y	8.53% 9.18%	Current Ratio	1.28	EPS Q/Q	13.64%	SMA20	6.86%	Beta	0.45	Target Price	312.71
Payout	119.05%	Debt/Eq	5.67	Sales Q/Q	13.32%	SMA50	10.14%	Rel Volume	0.74	Prev Close	315.59
Employees	28000	LT Debt/Eq	5.45	Earnings	Nov 04 AMC	SMA200	9.28%	Avg Volume	2.34M	Price	319.31
IPO	Jun 17, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.37% 6.59%	Trades		Volume	1,254,869	Change	1.18%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-03-25	Resumed	Raymond James	Mkt Perform
May-20-25	Resumed	Guggenheim	Neutral	$288
Apr-22-25	Resumed	Cantor Fitzgerald	Neutral	$305
Dec-10-24	Resumed	BofA Securities	Underperform	$256
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-14-24	Initiated	Citigroup	Neutral	$335
Oct-17-24	Initiated	Bernstein	Outperform	$380
Oct-14-24	Downgrade	Truist	Buy → Hold	$320 → $333
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270

Show Previous Ratings

Today 12:18PM	Amgen Stock: New All-Time Highs Ahead After Earnings Beat (MarketBeat)
08:20AM	ETF inflows surge as health care names lead gains amid easing headwinds (CNBC TV)
Nov-06-25 08:00AM	GoodRx Holdings Inc (GDRX) Q3 2025 Earnings Call Highlights: Strong Manufacturer Solutions ... (GuruFocus.com)
04:56AM	Company News for Nov 6, 2025 (Zacks)
Nov-05-25 04:33PM	U.S. Markets Stabilize After Tech Rout (The Wall Street Journal) +7.81%
04:28PM	Loading…
04:28PM	Amgen Surges On Broad-Based Beat As Investors Zone In On Obesity (Investor's Business Daily)
04:05PM	Heres How Markets Closed After the Supreme Court Heard Tariff Arguments (The Wall Street Journal)
02:26PM	Why Amgen Stock Was Crushing It on Wednesday (Motley Fool)
02:03PM	Royalty Pharma PLC (RPRX) Q3 2025 Earnings Call Highlights: Strong Portfolio Growth and ... (GuruFocus.com)
01:43PM	Heres How Markets Are Moving After the Supreme Court Heard Tariff Arguments (The Wall Street Journal)
11:41AM	Amgen Surges After Lifting Forecast--New Drugs and Obesity Bet Ignite Investor Hopes (GuruFocus.com)
11:37AM	Amgen's Q3 Earnings & Sales Beat, 2025 Outlook Raised, Stock Up (Zacks)
09:20AM	Here Are Wednesdays Top Wall Street Analyst Research Calls: Amgen, Cloudflare, Shopify, Super Micro Computer, Wingstop and More (24/7 Wall St.)
09:14AM	Stock Market Today: Dow Rises On Surprise Jobs Data; AMD Tumbles On Earnings (Live Coverage) (Investor's Business Daily)
08:36AM	AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance (StockStory)
05:16AM	Loading…
05:16AM	Analyst Report: Amgen Inc. (Morningstar Research)
12:01AM	Amgen Inc (AMGN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-04-25 08:00PM	Amgen (AMGN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
06:13PM	Markets Stay Lower on Valuation Questions: AI, etc. (Zacks)
05:15PM	Amgen (AMGN) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:47PM	Amgen beats third-quarter forecasts aided by one-offs, shares up (Investing.com)
04:33PM	Amgen (NASDAQ:AMGN) Delivers Strong Q3 Numbers (StockStory)
04:33PM	Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump (The Wall Street Journal)
04:13PM	Amgen: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Amgen Crushes Third-Quarter Expectations On The Back Of Two Blockbusters (Investor's Business Daily)
04:01PM	AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS (PR Newswire)
11:18AM	Stock Market Today: Investors Turn to Earnings from AMD, Arista Networks, and Rivian After Rough Day of Trading (TheStreet)
09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
08:14AM	Breen: Tariffs are not really landing on the industry (CNBC TV)
04:13AM	McDonalds Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week (The Wall Street Journal)
06:17PM	Loading…
Nov-03-25 06:17PM	Does the Market Have Bad Breadth? (Zacks)
11:41AM	Novo Nordisk Before Q3 Earnings: How Should Investors Play the Stock? (Zacks)
02:42AM	McDonalds Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week (The Wall Street Journal)
Nov-02-25 10:05PM	Amgen Earnings: What To Look For From AMGN (StockStory)
07:40AM	Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week (Yahoo Finance)
Oct-31-25 07:00PM	SNAP benefits expire, open enrollment, earnings: What to Watch (Yahoo Finance Video)
04:01PM	AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND (PR Newswire)
12:41PM	How Royalty Pharma Prints Cash Without Biotech's Biggest Risks (MarketBeat)
11:00AM	Agilent selects Adam Elinoff as CFO (MedTech Dive)
10:51AM	Demographic Megatrend: Stocks Poised to Benefit From Global Aging (Zacks)
09:17AM	Stock Market Today: Dow Rises On Amazon, Apple Earnings; Nvidia, Palantir Rebound (Live Coverage) (Investor's Business Daily)
09:00AM	Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know (Zacks)
09:00AM	AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025 (PR Newswire)
07:37AM	Amgen Stock: Analyst Estimates & Ratings (Barchart)
05:53AM	CFOs On the Move: Week ending Oct. 31 (CFO.com)
Oct-30-25 09:15AM	Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Oct-29-25 05:00PM	Gregory C. Garland Named to ExxonMobil Board of Directors (Business Wire)
04:01PM	AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS (PR Newswire)
03:08PM	Trump Administration Eases Approval Process for Biosimilar Drugs (Barrons.com)
11:27AM	Amgen's Q3 Earnings in the Cards: Here's What to Expect (Zacks)
10:00AM	Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:54AM	Stock Market Today: Dow Rises Ahead Of Fed Rate Decision, Powell; Nvidia Surges To New Highs (Live Coverage) (Investor's Business Daily)
Oct-28-25 10:13AM	As Dow Hits Record, High-Yield Dogs of the Dow Still a Bargain (24/7 Wall St.)
10:00AM	Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline (Zacks)
Oct-27-25 07:17PM	Agilent Technologies Names Adam S. Elinoff as CFO (Exec Edge)
11:32AM	Dr. Reddy's Q2 Earnings Beat Estimates, Generics Sales Boost Revenues (Zacks)
08:32AM	2 Value Stocks on Our Watchlist and 1 Facing Headwinds (StockStory)
Oct-24-25 11:32AM	The Zacks Analyst Blog Highlights Amazon.com, Wells Fargo, Amgen, IDT and Village Super Market (Zacks)
10:00AM	1 Top Dividend Growth Stock to Buy Right Now (Motley Fool)
Oct-23-25 05:50PM	Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know (Zacks)
04:41PM	Top Research Reports for Amazon.com, Wells Fargo & Amgen (Zacks)
Oct-22-25 07:22PM	Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
06:00PM	Why Amgen (AMGN) Dipped More Than Broader Market Today (Zacks)
Oct-21-25 09:13AM	Johnson & Johnson Targets Accelerated Growth Across Segments in 2026 (Zacks)
Oct-20-25 09:00AM	Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock (Zacks)
12:03AM	2 Reasons to Like AMGN and 1 to Stay Skeptical (StockStory)
Oct-17-25 04:00PM	FDA APPROVES TEZSPIRE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (PR Newswire)
06:22AM	The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics (Zacks)
Oct-16-25 09:31AM	How Will Mounjaro and Zepbound Sales Aid Lilly's Upcoming Q3 Results? (Zacks)
01:59AM	Oppenheimer Highlights Amgen's (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study (Insider Monkey)
Oct-15-25 05:50PM	Amgen (AMGN) Laps the Stock Market: Here's Why (Zacks)
Oct-14-25 01:06PM	Amgen (AMGN) Announces Launch of AmgenNow (Insider Monkey)
12:00PM	JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit (Zacks)
Oct-13-25 12:10PM	Why Amgen (AMGN) Could Beat Earnings Estimates Again (Zacks)
08:43AM	Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention (Insider Monkey)
Oct-12-25 11:32PM	Reflecting On Therapeutics Stocks' Q2 Earnings: Amgen (NASDAQ:AMGN) (StockStory)
Oct-10-25 12:10PM	Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know (Zacks)
04:41AM	Here's What to Expect From Amgens Next Earnings Report (Barchart)
Oct-09-25 11:55AM	What Do Charts Say About the Dow? 3 Favorite Stocks That Could Lead a Year-End Push (Barrons.com)
11:00AM	Is Novo Nordisk Stock a Sell Despite its 10% Price Rally in a Month? (Zacks)
Oct-08-25 09:00AM	Is Trending Stock Amgen Inc. (AMGN) a Buy Now? (Zacks)
12:35AM	2 S&P 500 Stocks to Target This Week and 1 Facing Challenges (StockStory)
Oct-07-25 01:45PM	Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60% (Zacks)
Oct-06-25 05:50PM	Amgen (AMGN) Stock Sinks As Market Gains: Here's Why (Zacks)
03:23PM	Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Cheaper Online (GuruFocus.com)
11:09AM	Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts (The Wall Street Journal)
09:40AM	Here's Why Amgen (AMGN) is a Strong Value Stock (Zacks)
09:00AM	AMGEN MAKES REPATHA AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. (PR Newswire)
08:32AM	How J&J's Innovative Medicines Segment is Poised Ahead of Q3 Results (Zacks)
Oct-04-25 06:45AM	4 Reasons to Buy Amgen Stock Right Now (Motley Fool)
Oct-03-25 11:10AM	Cramer's Stop Trading: Amgen (CNBC TV)
07:46AM	Long-term benefit of Amgens Repatha in reducing MACE shown in Phase III trial (Clinical Trials Arena)
07:46AM	Amgens Phase III data supports FDA label expansion of Repatha (Pharmaceutical Technology)
07:46AM	Amgens Phase III data cements FDA decision to expand Repatha label (Clinical Trials Arena)
Oct-02-25 09:50AM	Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term (Zacks)
09:23AM	Stock Market News for Oct 2, 2025 (Zacks)
09:00AM	LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS (PR Newswire)
07:53AM	Amgen claims landmark study result that could widen heart drugs use (BioPharma Dive)
07:00AM	Bruce Beutler Unlocked Key Mystery To Disease And He's Not Done (Investor's Business Daily)
03:26AM	2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer (Motley Fool)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	Aug 20 '25	Sale	296.99	1,267	376,280	7,209	Aug 22 07:21 PM
Grygiel Nancy A.	Officer	Aug 20 '25	Proposed Sale	294.32	1,267	372,909		Aug 20 04:31 PM
Khosla Rachna	SVP, Business Development	Jun 05 '25	Sale	289.68	1,500	434,520	8,162	Jun 06 07:49 PM
Khosla Rachna	Officer	Jun 05 '25	Proposed Sale	290.00	1,500	435,000		Jun 05 12:24 PM
Busch Matthew C.	VP, Finance & CAO	May 02 '25	Sale	279.69	1,000	279,690	4,034	May 06 08:07 PM
Busch Matthew C.	Officer	May 02 '25	Proposed Sale	281.44	1,000	281,440		May 02 02:37 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	80,257	Feb 21 08:07 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Sale	292.84	8,711	2,550,903	71,546	Feb 21 08:07 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	70,858	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 21 '25	Sale	304.44	25,225	7,679,524	36,922	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Sale	293.22	8,711	2,554,224	62,147	Feb 21 08:06 PM
DAVID M REESE & JOAN I CHUCO-T	Officer	Feb 21 '25	Proposed Sale	304.44	25,225	7,679,524		Feb 21 04:27 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Option Exercise	156.35	1,524	238,277	10,068	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Sale	293.74	1,524	447,655	8,544	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 18 '25	Sale	292.56	500	146,279	8,544	Feb 20 08:59 PM
DEREK MILLER	Officer	Feb 19 '25	Proposed Sale	293.74	1,524	447,655		Feb 19 04:18 PM
DAVID REESE	Officer	Feb 19 '25	Proposed Sale	293.22	8,711	2,554,224		Feb 19 04:14 PM
Santos Esteban	Affiliate	Feb 19 '25	Proposed Sale	292.11	8,711	2,544,570		Feb 19 02:25 PM
DEREK MILLER	Officer	Feb 18 '25	Proposed Sale	292.56	500	146,279		Feb 18 04:10 PM
Gordon Murdo	EVP, Global Commercial Ops	Feb 11 '25	Sale	294.79	8,771	2,585,644	44,186	Feb 13 09:02 PM
Gordon Murdo	Officer	Feb 11 '25	Proposed Sale	295.30	8,771	2,590,076		Feb 11 03:01 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Option Exercise	156.35	25,045	3,915,786	54,032	Feb 10 09:52 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Sale	293.12	25,045	7,341,123	28,987	Feb 10 09:52 PM
Graham Jonathan P	Officer	Feb 07 '25	Proposed Sale	292.94	25,045	7,336,682		Feb 07 03:05 PM
Grygiel Nancy A.	SVP & CCO	Feb 05 '25	Sale	304.47	1,589	483,808	7,210	Feb 06 08:54 PM
Grygiel Nancy A.	Officer	Feb 05 '25	Proposed Sale	304.47	1,589	483,800		Feb 05 12:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc

Upgrade your FINVIZ experience